Clinical Trial Update: ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Eureka Therapeutics reports a Phase 1/2 trial recruiting pediatric patients with hepatoblastoma, hepatocellular carcinoma, and related liver neoplasms to evalua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoblastoma
• Hepatocellular Carcinoma

Drugs mentioned

• ET140203 T cells

Snippet

Sponsor: Eureka Therapeutics Inc. | Conditions: Hepatoblastoma, Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: RECRUITING